Sightline Wealth Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$424K	Buy	9,684 +55	+0.6%	+$2.54K	0.18%	59
2025 Q4	$438K	Sell	9,629 -1,203	-11%	-$53.3K	0.19%	62
2025 Q3	$421K	Sell	10,832 -1,575	-13%	-$57K	0.19%	62
2025 Q2	$418K	Sell	12,407 -387	-3%	-$12.3K	0.2%	60
2025 Q1	$407K	Sell	12,794 -2,690	-17%	-$102K	0.21%	55
2024 Q4	$601K	Sell	15,484 -827	-5%	-$34.7K	0.32%	44
2024 Q3	$734K	Sell	16,311 -150	-0.9%	-$6.71K	0.4%	41
2024 Q2	$687K	Buy	16,461 +950	+6%	+$39.7K	0.43%	39
2024 Q1	$706K	Sell	15,511 -450	-3%	-$20.5K	0.47%	35
2023 Q4	$738K	Sell	15,961 -2,113	-12%	-$86.1K	0.56%	35
2023 Q3	$735K	Buy	18,074 +16	+0.1%	+$728	0.69%	34
2023 Q2	$890K	Hold	18,058	–	–	0.88%	26
2023 Q1	$890K	Sell	18,058 -275	-2%	-$14.2K	0.91%	24
2022 Q4	$928K	Buy	18,333 +4,728	+35%	+$244K	1%	24
2022 Q3	$685K	Buy	13,605 +3,364	+33%	+$190K	0.8%	20
2022 Q2	$501K	Buy	10,241 +5,247	+105%	+$266K	0.49%	30
2022 Q1	$300K	Buy	4,994 +1,273	+34%	+$80.3K	0.25%	44
2021 Q4	$291K	Buy	+3,721	New	+$313K	0.26%	39